Abali H - Search Results

1

Continuous distress in an oncology clinic in Turkey: should we make use of the distress thermometer mandatory as a precautionary measure for physicians?

Sumbul AT, Sezer A, Abali H, Dicel U, Gultepe I, Besen AA, Ozyilkan O. Sumbul AT, et al. Among authors: abali h. J BUON. 2014 Jul-Sep;19(3):807-11. J BUON. 2014. PMID: 25261671 Free article.

2

Little dose, huge toxicity: profound hematological toxicity of intrathecal methotrexate.

Kose F, Abali H, Sezer A, Mertsoylu H, Disel U, Ozyilkan O. Kose F, et al. Among authors: abali h. Leuk Lymphoma. 2009 Feb;50(2):282-3. doi: 10.1080/10428190802603169. Leuk Lymphoma. 2009. PMID: 19197737 No abstract available.

3

Immediate or delayed docetaxel: does progression-free survival really reflect two strategies?

Abali H, Disel U, Köse F, Sezer A, Mertsoylu H. Abali H, et al. J Clin Oncol. 2009 Jun 10;27(17):2889; author reply 2889. doi: 10.1200/JCO.2009.22.3305. Epub 2009 Apr 27. J Clin Oncol. 2009. PMID: 19398567 No abstract available.

4

Unilateral hand-foot syndrome: an extraordinary side effect of capecitabine.

Disel U, Gürkut O, Abali H, Kaleağasi H, Mertsoylu H, Ozyilkan O, Saif MW. Disel U, et al. Among authors: abali h. Cutan Ocul Toxicol. 2010 Jun;29(2):140-2. doi: 10.3109/15569521003699585. Cutan Ocul Toxicol. 2010. PMID: 20298142

5

Promising efficacy of sorafenib in a relapsed thymic carcinoma with C-KIT exon 11 deletion mutation.

Dişel U, Oztuzcu S, Beşen AA, Karadeniz C, Köse F, Sümbül AT, Sezer A, Nursal GN, Abalı H, Ozyılkan O. Dişel U, et al. Among authors: abali h. Lung Cancer. 2011 Jan;71(1):109-12. doi: 10.1016/j.lungcan.2010.09.011. Lung Cancer. 2011. PMID: 20970876

6

Socio-demographic parameters in screening for breast cancer: Lessons from a population-'based women's Health Project held in a province in Turkey.

Hayran M, Abali H, Kilickap S, Mentes T, Aksoy H, Kemik A, Gokce H, Gokdemir H, Toplar S, Kaya D, Isbir GG. Hayran M, et al. Among authors: abali h. J BUON. 2010 Oct-Dec;15(4):726-31. J BUON. 2010. PMID: 21229637

7

Severe systemic vasoconstriction starting with acute limb ischemia leading to death in a patient with well-differentiated pulmonary neuroendocrine carcinoma: a new paraneoplastic syndrome?

Karadeniz C, Köse F, Abali H, Sümbül AT, Oğuzkurt L, Karabacak T, Oberg K. Karadeniz C, et al. Among authors: abali h. Acta Oncol. 2012 Jan;51(1):124-7. doi: 10.3109/0284186X.2011.602115. Epub 2011 Aug 22. Acta Oncol. 2012. PMID: 21859354 No abstract available.

8

Safety and efficacy of FOLFIRI-bevacizumab for metastatic colorectal carcinoma as second line treatment.

Odabas H, Ozdemir N, Isik M, Abali H, Oksuzoglu B, Kos T, Civelek B, Babacan AN, Dogan U, Zengin N. Odabas H, et al. Among authors: abali h. J BUON. 2011 Jul-Sep;16(3):460-3. J BUON. 2011. PMID: 22006750

9

Patients with advanced cholangiocarcinoma benefit from chemotherapy if they are fit to receive it: single center experience.

Kose F, Abali H, Sezer A, Ali Besen A, Taner Sumbul A, Karadeniz C, Disel U, Ozyilkan U. Kose F, et al. Among authors: abali h. J BUON. 2011 Jul-Sep;16(3):469-72. J BUON. 2011. PMID: 22006752

10

Frequency of comorbid illnesses in cancer patients in Turkey.

Abali H, Ata A, Ozdogan M, Turhal S, Cabuk D, Seyrek E, Senol Coskun H, Arik Z, Erman M, Celik I. Abali H, et al. J BUON. 2011 Jul-Sep;16(3):557-60. J BUON. 2011. PMID: 22006766

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

135 results

Search Page

Filters